Novartis is acquiring U.S. biotech firm Avidity Biosciences for approximately $12 billion in cash to expand its rare disease treatment port...

European shares edged higher on Monday, recovering some ground after a sharp selloff on Friday, while Swiss stocks slumped to their lowest ...

"While the exact revenue from Entresto-related supplies is undisclosed, it contributes a meaningful share to the overall business. However,...

DMF, as the solvent is known, is classified by the World Health Organization as a probable carcinogen.

The Nikkei share average ended 0.2 per cent higher to 21,464.23.

Until now to buy into an Indian enterprise, multinational drug companies needed an approval from FIPB under department of industrial policy...

The annual report released by the FDA’s OGD shows Indian companies have won some key approvals in the world’s biggest pharmaceuticals marke...

Sun Pharmaceutical announced it received approval from the US FDA for generic copies of Gleevec, a drug that treats chronic myeloid leukemi...

Google Life Sciences entered a partnership with Sanofi, a European pharmaceutical company, to develop technologies to treat diabetes.

Ranbaxy should be able to generate $190 million of sales and an after-tax profit of $100 million during 180 days, said a research analyst.

The collaboration between the two will create a new world-leading consumer healthcare business with $10 billion in annual sales.

The pharma sector, estimated to be around Rs 1.5 lakh cr, recorded single digit growth for the first time in many years on account of deepe...

The latest growth numbers released for the month of February 2013 do not hold good news for the Indian pharma industry.

News Corp today announced a major restructuring of its top management in line with its decision to split into two publicly traded firms.

Teva Pharmaceutical Industries Ltd named Jeremy Levin of Bristol-Myers Squibb Coto to replace Shlomo Yanai as chief executive officer.

Shares of multinational pharmaceutical companies on Wednesday extended gains on the BSE, cheering their parents’ move to hike stake in thes...

On January 25 this year, the patent office in Chennai rejected a patent application by pharma MNC Novartis for its anti-cancer drug Glivec ...